13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

OSSEOFLEX SB

FDA 510(k)
FDA Class 2 ·Orthopedic

MEDI

FDA UDI
MEDI MANUFACTURING, INC.·00636257142530·20-30 MFW VITALITY CALF CT CHOC VII

MEDI

FDA UDI
MEDI MANUFACTURING, INC.·00636257125410·20-30 MV FOR MEN CLSC CALF STD BROWN VII

PC CARE BLOOD GLUCOSE DATA MANAGEMENT SOFTWARE

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

TEM 3000 HEAD COIL

FDA 510(k)
FDA Class 2 ·Radiology

INCLUSIVE MINI IMPLANT O-BALL 3.0 MMD X 13 MML

FDA Adverse Event
Injury ·PRISMATIK DENTALCRAFT, INC.·Product code DZE·August 29, 2024

Medline Microdissection Needle (4cm) (140936 (ESE104A)); Medline Microdissection Needle (3cm) (140937 (ESE103A))

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

ESSURE

FDA Adverse Event
Injury ·BAYER PHARMA AG·Product code HHS·September 6, 2019

UNKNOWN DEPUY ASR FEMORAL HEAD

FDA Adverse Event
Injury ·DEPUY INTL., LTD. - 8010379·Product code KWA·June 3, 2013

PROSTAR XL SUTURE-MEDIATED CLOSURE

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·June 27, 2011

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS INC.·Product code JAA·September 3, 2008

NAVIS-EX , Image Filing Software for NIDEK AFC Fundus camera, Ver 1.1.0 to 1.3.5. NAVIS-EX is indicated for use as file management software for ophthalmic images.

FDA Enforcement
Class II ·Terminated·Nidek Inc·September 4, 2013

C-Series High Energy Linear Accelerator - Models: Novalis Tx, Trilogy, Trilogy Tx, Clinac iX, Clinac 2100 C/D, Clinac 2300C/D, Clinac 21EX, Clinac 23EX with versions 7, 8, 9 and 6 MV configuration and maximum dose rate of at least 6000 MU/min only. Varian High Energy Linear Accelerator is intended to provide sterotactic radiosurgery and precision radio-therapy for lesions, tumors and conditions anywhere in the body when radiation treatment is indicated.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems, Inc.·September 24, 2014